CLIMB BIO, INC. Basic Shares Outstanding (Weighted Average)
CLIMB BIO, INC. (CLYM) reported Basic Shares Outstanding (Weighted Average) of 76.15 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- CLIMB BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 76.15M shares, a 12.68% increase year-over-year.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 68.21M shares, a 1.10% increase year-over-year.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 68.19M shares, a 1.21% increase year-over-year.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 68.00M shares, a 1.48% increase year-over-year.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 67.81M shares, a 40.80% increase from fiscal 2024.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 48.16M shares, a 78.47% increase from fiscal 2023.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 26.99M shares, a 2.57% increase from fiscal 2022.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 26.31M shares, a 114.60% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 76.15M shares 10-Q · filed 2026-08-06 | 72.20M shares 10-Q · filed 2026-08-06 | 70.85M shares derived: average of 3 quarters · filed 2026-08-06 | 70.14M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 68.21M shares 10-Q · filed 2026-05-07 | 68.20M shares derived: average of 2 quarters · filed 2026-05-07 | 68.13M shares derived: average of 3 quarters · filed 2026-05-07 | 68.00M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 68.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 68.10M shares derived: average of 2 quarters · filed 2026-03-05 | 67.93M shares derived: average of 3 quarters · filed 2026-08-06 | 67.81M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 68.00M shares 10-Q · filed 2025-11-06 | 67.79M shares derived: average of 2 quarters · filed 2026-08-06 | 67.69M shares 10-Q · filed 2025-11-06 | 67.61M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 67.59M shares 10-Q · filed 2026-08-06 | 67.52M shares 10-Q · filed 2026-08-06 | 67.47M shares derived: average of 3 quarters · filed 2026-08-06 | 67.36M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 67.46M shares 10-Q · filed 2026-05-07 | 67.42M shares derived: average of 2 quarters · filed 2026-05-07 | 67.28M shares derived: average of 3 quarters · filed 2026-05-07 | 58.05M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 67.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 67.19M shares derived: average of 2 quarters · filed 2026-03-05 | 54.91M shares derived: average of 3 quarters · filed 2026-03-05 | 48.16M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 67.01M shares 10-Q · filed 2025-11-06 | 48.68M shares derived: average of 2 quarters · filed 2025-11-06 | 41.76M shares 10-Q · filed 2025-11-06 | 38.14M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | 30.35M shares 10-Q · filed 2025-08-12 | 28.99M shares 10-Q · filed 2025-08-12 | 28.51M shares derived: average of 3 quarters · filed 2025-08-12 | 28.15M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 27.64M shares 10-Q · filed 2025-05-14 | 27.59M shares derived: average of 2 quarters · filed 2025-05-14 | 27.42M shares derived: average of 3 quarters · filed 2025-05-14 | 27.27M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 27.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | 27.30M shares derived: average of 2 quarters · filed 2025-03-25 | 27.15M shares derived: average of 3 quarters · filed 2025-03-25 | 26.99M shares 10-K · filed 2025-03-25 |
| 2023-09-30 | 27.07M shares 10-Q · filed 2024-11-12 | 26.96M shares derived: average of 2 quarters · filed 2024-11-12 | 26.80M shares 10-Q · filed 2024-11-12 | 26.69M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 26.84M shares 10-Q · filed 2024-08-14 | 26.67M shares 10-Q · filed 2024-08-14 | 26.57M shares derived: average of 3 quarters · filed 2024-08-14 | 26.51M shares derived: average of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | 26.49M shares 10-Q · filed 2024-05-15 | 26.43M shares derived: average of 2 quarters · filed 2024-05-15 | 26.40M shares derived: average of 3 quarters · filed 2024-05-15 | 26.37M shares derived: average of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | 26.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 26.35M shares derived: average of 2 quarters · filed 2024-03-28 | 26.34M shares derived: average of 3 quarters · filed 2024-03-28 | 26.31M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 26.34M shares 10-Q · filed 2023-11-14 | 26.32M shares derived: average of 2 quarters · filed 2023-11-14 | 26.29M shares 10-Q · filed 2023-11-14 | 26.31M shares derived: average of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | 26.30M shares 10-Q · filed 2023-08-10 | 26.27M shares 10-Q · filed 2023-08-10 | 26.30M shares derived: average of 3 quarters · filed 2023-08-10 | 23.63M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 26.24M shares 10-Q · filed 2023-05-11 | 26.31M shares derived: average of 2 quarters · filed 2023-05-11 | 22.73M shares derived: average of 3 quarters · filed 2023-05-11 | 17.92M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 26.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 20.98M shares derived: average of 2 quarters · filed 2023-03-06 | 15.15M shares derived: average of 3 quarters · filed 2023-03-06 | 12.26M shares 10-K · filed 2023-03-06 |
| 2021-09-30 | 15.59M shares 10-Q · filed 2022-11-14 | 9.54M shares derived: average of 2 quarters · filed 2022-11-14 | 7.55M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 3.49M shares 10-Q · filed 2022-08-15 | 3.47M shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |